Daniel H Ahn (Daniel Ahn)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Ejection Fraction

Replacement Therapy

Metastatic Colorectal Cancer

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Pedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam B Sonbol, Daniel H Ahn, Jason S Starr, Jeremy C Jones, Hani M Babiker, Samantha R Inabinett, Natasha Wylie, Ashton W R Boyle, Tanios S Bekaii-Saab, Gregory J Gores, Rory Smoot, Michael Barrett, Bolni Marius Nagalo, Nathalie Meurice, Natalie M Elliott, Joachim Petit, Yumei Zhou, Mansi Arora, Chelsae Dumbauld, Oumar Barro, Alexander T Baker, James Bogenberger, Kenneth H Buetow, Aaron S Mansfield, Kabir Mody, Mitesh J Borad
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 6 (2022)
Daniel H Ahn, Michelle Sidel, Laura E Panattoni, Naomi Sacks, Jennifer Hernandez, Reginald Villacorta
Real-world outcomes in patients with first-line and second-line therapy for advanced esophageal squamous cell carcinoma. Future oncology (London, England) 18 (30) (2022)
Reza Arsanjani, Pradyumna Agasthi, Daniel H Ahn, Farouk Mookadam, Ming Yang
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality Imaging. Korean circulation journal 49 (6) (2019)
Mohamad Bassam B Sonbol, Belal Firwana, Zhen Wang, Diana Almader-Douglas, Mitesh J Borad, Issam Makhoul, Ramesh K Ramanathan, Daniel H Ahn, Tanios Bekaii-Saab
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis. Cancer 123 (23) (2017)
Daniel H Ahn, Josh Reardon, Chul W Ahn, Manojkumar Bupathi, Sameh Mikhail, Christina Sing-Ying Wu, Tanios Bekaii-Saab
Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer. International journal of cancer 142 (8) (2017)